Non-small cell to small cell lung cancer on PD-1 inhibitors: two cases on potential histologic transformation
Nadine Abdallah,1 Misako Nagasaka,2,3 Eman Abdulfatah,4 Dongping Shi,4 Antoinette J Wozniak,2 Ammar Sukari2 1Department of Internal Medicine, Wayne State University, Detroit, MI 48201, USA; 2Department of Oncology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, De...
Main Authors: | Abdallah N, Nagasaka M, Abdulfatah E, Shi D, Wozniak AJ, Sukari A |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2018-10-01
|
Series: | Lung Cancer : Targets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/non-small-cell-to-small-cell-lung-cancer-on-pd-1-inhibitors-two-cases--peer-reviewed-article-LCTT |
Similar Items
-
A retrospective study evaluating the pretreatment tumor volume (PTV) in non-small cell lung cancer (NSCLC) as a predictor of response to program death-1 (PD-1) inhibitors
by: Nagasaka M, et al.
Published: (2019-09-01) -
Clinical Development of Immune Checkpoint Inhibitors in Patients with Small Cell Lung Cancer
by: Shuang ZHANG, et al.
Published: (2017-09-01) -
Achievements and futures of immune checkpoint inhibitors in non-small cell lung cancer
by: Zhenbin Qiu, et al.
Published: (2019-08-01) -
Progress in Clinical Researches of PD-1/PD-L1 Checkpoint Inhibitor for
Non-small Cell Lung Cancer
by: Sixuan WU, et al.
Published: (2019-07-01) -
New PD-L1 inhibitors in non-small cell lung cancer – impact of atezolizumab
by: Seetharamu N, et al.
Published: (2017-07-01)